With this extension, IXCHIQ®, the first vaccine against the chikungunya virus (CHIKV), is now available for administration for individuals 12 years of age and older in the European Union (EU).
In response to soaring egg prices and supply shortages driven by a devastating bird flu outbreak, the United States is ...
The Pan American Health Organisation (PAHO) Monday issued a new epidemiological alert in response to an increase in yellow ...
The measles vaccine uses a weakened virus that's never been shown to spread to others. Samples from the outbreak in Texas ...
The CDC issued a warning last week that cases of dengue fever, a virus that can be deadly, are continuing to rise across the ...
Dengue fever threatens Australia's outdoor way of life, but a new creature could soon help stop its spread. Find out how.
The Brazil aluminum market was valued at $2.2 billion in 2019 and is expected to reach $4.1 billion by 2028, growing at a CAGR of 4.4% from 2021 to 2028. Aluminum is a lightweight, nonmagnetic, soft, ...
New York City was at the epicenter of the COVID-19 pandemic, losing 46,000 residents â€” but five years later, a memorial to ...
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it has submitted a label extension application to the Medicines and Healthcare products Regulatory ...
Several studies have reported that the coronavirus disease 2019 (COVID-19) can lead to heart rate variability (HRV), with the ...
New research suggests a link between HPV and heart disease, highlighting the potential benefits of HPV vaccination beyond ...